The recent A*STAR Scientist-Entrepreneur Award was presented by the Agency of Science, Technology and Research (A*STAR) to Curiox on the 14th of April. The A*STAR awards were introduced in 2007 to recognise outstanding staff for their contributions to A*STAR and to celebrate their achievements. Additionally, the awards serve to recognize staff and former staff who have successfully commercialized or spun off their research to the industry. Dr Kim is an ideal winner of the award, having spun out the research he led for four years on DropArray™ technology, at the Institute of Bioengineering and Nanotechnology (IBN), to the industry.

There were a total of 5 nominations for this year's A*STAR Scientist-Entrepreneur award, for which Dr Kim was selected. The evaluation panel comprised of Ms Yena Lim, Managing Director of A*STAR; Professor Low Teck Seng, Deputy Managing Director of A*STAR (Research); Mr Teoh Yong Sea, Deputy Managing Director (Corporate Planning); Professor Lee Eng Hin, Executive Director of the Biomedical Research Council and Director of Graduate Medical Studies at the National University of Singapore; Prof Chong Tow Chong, Executive Director of the Science and Engineering Research Council; and Dr Lim Khiang Wee, Executive Director of the Institute of Materials Research and Engineering. According to A*STAR the panel based their decision on the scientific and commercial impact of the spin-off, and industry recognition received by the start-up, under the leadership of the A*STAR entrepreneur.

Dr Kim commented, "I am truly honoured to receive this award and recognition from A*STAR. I would also like to thank my team, shareholders, Exploit Technologies and NUS Enterprise for all their input and guidance in bringing Curiox to the position it is today. As we expand into foreign markets this year, we look forward to many more successes."

About Curiox Biosystems Pte Ltd:

Curiox Biosystems has a vision to accelerate the progress of life sciences and drug discovery through better miniaturization. Curiox is a bioinstrumentation company enabling the miniaturization of bioassays for researchers working in life sciences, drug discovery, and diagnostics. Curiox's patent-pending miniaturization platform, DropArray™, provides up to 25 times savings in sample and reagent consumption, and up to 60 % reduction in assay time. The company is a spin-off from Institute of Bioengineering and Nanotechnology (IBN) backed primarily by Nanostart and Exploit Technologies, the commercializing arm of Singapore's Agency for Science, Technology and Research (A*STAR). For further information, please visit www.curiox.com.


For more information, Kindly contact:
Nicole Soo
nicole@curiox.com
180 Ang Mo Kio Avenue 8
Block Q, Unit # 501
Singapore 569830 
Singapore

กก